Seminars

Past seminars video recordings available on

2022
  • 04/04/2022 - Andrea Facciabene, Department of Radiation Oncology and the Ovarian Cancer Research Center (OCRC) University of Pennsylvania -"The impact of the gut microbiota on cancer immunology and immunotherapy”
  • 17/03/2022 - Lucilia Saraiva, Faculty of Pharmacy University of Porto -"Targeting p53 for cancer treatment and prevention”
  • 07/03/2022 - Andreas Leithner, Department of Orthopaedics and Trauma, Medical University of Graz -"Bone and soft tissue tumors: principles of treatment”
  • 18/02/2022 - Emilio Quaia, Dipartimento di Medicina, Università di Padova -"Contrast enhanced ultrasound in oncology
2021
  • 14/12/2021 - Cyril Corbet , Institut de Recherche Expérimentale et Clinique (IREC) University of Louvain (UCL) Medical School -"At the crossroads of tumor microenvironment and metabolism: role of acidosis in tumor evolution”
  • 30/11/2021 - Tim Pawlik, The Urban Meyer III and Shelley Meyer Chair for Cancer Research Wexner Medical Center - The Ohio State University (USA) -"Management of Intrahepatic Cholangiocarcinoma”
  • 11/11/2021 - Silvia Giunco, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche - Università di Padova -"The extra telomeric functions of telomerase in B cell malignancies”
  • 02/11/2021 - Paolo Strati, Department of Translational Molecular Pathology - UT MD Anderson Cancer Center Houston, TX -"Mitigating CAR T cell associated toxicities for patients with B cell Lymphoma: an ongoing challenge”
  • 27/10/2021 - Giulia Pasello, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche - Università di Padova -"Tumor immune microenvironment and circulating inflammatory markers for prognostic and predictive stratification of thoracic cancer patient”
  • 12/10/2021 - Angela Gallo, RNA Editing lab, Department of Oncohematology - IRCCS Ospedale Pediatrico Bambino Gesù Roma -"The essential role played by the rna editing mechanism in normal and oncology processes”
  • 04/10/2021 - Sandra Zampieri, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche - Università di Padova -"Denervation and neuromuscolar junction degeneration underlie muscle wasting in human cancer cachexia"
  • 26/05/2021 - Evelina Miele, Terapia Cellulare e Genica dei Tumori Pediatrici - IRCCS Ospedale Pediatrico Bambino Gesù, Roma -"DNA methylation profiling in pediatric brain tumors and sarcomas"
  • 11/05/2021 - Michael R. Ladomery, Faculty of Health and Applied Sciences, University of the West of England (Bristol) - “Targeting splicing in prostate cancer”
  • 27/04/2021 - Luca Mazzarella, Department of Experimental Oncology, European Institute of Oncology - "Dietary and metabolic modulation of cancer stem cells. Molecular mechanisms and potential targets"
  • 23/04/2021 - Angelo De Milito, Tumor Biology and Therapeutics, Sprint Bioscience - "Development of Vps34 inhibitors as immunomodulating agents for cancer therapy"
  • 18/03/2021 - Silvano Sozzani, Dipartimento di Medicina molecolare, Università di Roma "La Sapienza" - "A new lung homing pathway for NK cell antitumor immune surveillance"
  • 25/02/2021 - Renzo Pegoraro, Pontificia Accademia per la Vita (Roma) - "Etica nella ricerca e nella pratica clinica: due tipi di Comitato Etico"
  • 16/02/2021 - Maria Rescigno, Mucosal immunology and microbiota unit, Humanitas Research Hospital (Rozzano) - "The microbiota in tumor progression and treatment"
  • 13/01/2021 - Andrea Sottoriva, Centre for Evolution and Cancer, The Institute of Cancer Research (London) - "Measuring and predicting cancer evolution from genomic data and histopathological imaging"
2020
  • 10/12/2020 - Simone Becattini, Department of Pathology and Immunology, University of Geneva - "Adaptation of intestinal bacteria to host immune responses"
  • 26/11/2020 - Andrea Cozza, Dipartimento di Scienze Cardio-Toraco-Vascolari e Sanità Pubblica, Università di Padova - "La vaccinazione nella storia della Medicina"
  • 20/11/2020 - Lidia Bosurgi, Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf - "Impact of apoptotic cell identity on macrophage function"
  • 13/11/2020 - Nicola Gagliani, Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf - "CD4+ T cell biology, immunity and immune mediated inflammatory diseases"
  • 13/10/2020 - Andrea Cossarizza, Dipartimento di Scienze Mediche e Chirurgiche materno infantili e dell'adulto, Università di Modena e Reggio Emilia - "Immune system during COVID-19: whose side is it on"
  • 29/07/2020 - Enrico Lugli, Humanitas Flow Cytometry Core, Humanitas Clinical and Research Center (Rozzano) - "T cell differentiation at single-cell resolution"
  • 24/07/2020 - Dario Sangiolo, Dipartimento di Oncologia, Università di Torino - "Cancer Immunotherapy with CAR-redirected killer lymphocytes: Rational basis, current evidence and future perspective"
  • 15/07/2020 - Giuseppe Lombardi, Unità Operativa Complessa Oncologia 1, Istituto Oncologico Veneto IRCCS (Padova) - "New treatment perspectives for glioblastoma"
  • 10/07/2020 - Stefano Indraccolo, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova - "Genetic, epigenetic and immunological characterization of relapsed glioblastoma"
  • 26/06/2020 - Susanna MandruzzatoDipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova - "Role of myeloid cells in the immune escape strategies of glioblastoma"
  • 19/06/2020 - Piero Dalerba, Department of Pathology and Cell Biology, Columbia University Irving Medical Center (New York) - "The “cancer stem cell” model: a guide to biomarker discovery and therapeutic decisions in human colon cancer"
  • 12/06/2020 - Serena Pellegatta, Unità Operativa Complessa di Neuro-Oncologia Molecolare, Istituto Neurologico Carlo Besta IRCCS (Milano) - "Chimeric Antigen Receptor (CAR) -T: opportunities, challenges and implications for the treatment of glioblastoma"
  • 29/05/2020 - Gaetano FinocchiaroUnità Operativa Complessa di Neuro-Oncologia Molecolare, Istituto Neurologico Carlo Besta IRCCS (Milano) - "Glioblastoma immunotherapy with dendritic cells: what we are learning"
  • 14/02/2020 - Ornella Morana, Instituto Biofisika, University of the Basque Country (Bilbao) - "Capturing in situ snapshots of lipidprotein interactions in living cells"
  • 12/02/2020 - Giovanni Tonon, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute IRCCS (Milano) - "Single cell cancer evolution in the clinic"
  • 10/02/2020 - Ugo Cavallaro, Unità di Ricerca in Ginecologia Oncologica, Istituto Europeo di Oncologia (Milano) - "New players and targets in ovarian cancer stem cells" 
  • 22/01/2020 - Matteo Bellone, Cellular Immunology Unit, San Raffaele Scientific Institute IRCCS (Milano) - "Microbiota immune cells crosstalk in multiple myeloma"
2019 
  • 12/11/2019 - Riccardo Dalla Favera, Institute for Cancer Genetics, Columbia University (New York) - "Genomics of B cell lymphoma and its implications for therapy"
  • 08/10/2019 - Alessandra Buja, Dipartimento di Scienze Cardio-Toraco-Vascolari e Sanità Pubblica, Università di Padova - "Costi del PDTA del Melanoma nel Veneto e impatto nel processo decisionale"
  • 08/10/2019 - Elena Pizzo, Department of Applied Health Research, University College (London) - "The role of health economics and HTA in health care and cancer treatment"
  • 07/10/2019 - Raffaele Baffa, Servier Pharmaceuticals (Boston) - "Early decision making in oncology drug development"
  • 09/05/2019 - Giulia Pasqual, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova - "A cellular LIPSTIC to track cell cell interaction in vivo"
  • 07/05/2019 - Francesco Dazzi, King's College (London) - "Mesenchymal stromal cells: a matter of life death"
  • 17/04/2019 - Giovanni Tonon, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute IRCCS (Milano) - "Tumor suppressor genes: are we there yet?"
  • 27/03/2019 - Adam Zweifach, Department of Molecular and C ell Biology, University of Connecticut (Storrs) - "Journeying with Cytotoxic T lymphocytes from signaling to phenotypic screening and some lessons learned along the way"
  • 13/03/2019 - Alessandra Biffi, Dipartimento di Salute della Donna e del Bambino, Università di Padova - "Advances in the application of HSC gene therapy for neurometabolic and neurodegenerative diseases"
  • 12/03/2019 - NIccolò Bolli, Dipartimento di Oncologia ed Emato-Oncologia, Università di Milano - "Selective killing of T-acute lymphoblastic leukemia (T-ALL) cells by activation of the ROS-OMA1-OPA1 axis"
  • 12/03/2019 - Lena Pernas, Max-Planck-Institute for Biology of Ageing (Cologne) - "The metabolism of infection"
  • 04/03/2019 - Giorgia Simonetti, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS (Meldola) - "Leucemia acuta mieloide e metabolismo: integrazione di profili genomici e metabolomici"
  • 25/02/2019 - Anna Tosi, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova - "The fluorescent multiplex immunochemistry"
  • 13/02/2019 - Diego Cecchin, Dipartimento di Medicina, Università di Padova - "Utilizzo della PET/RM nella pratica clinica"
  • 05/02/2019 - Erich Piovan, Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova - "Applications of the CRISPR-CAS9 system in cancer biology: modeling of WT1 loss in T-cell leukemia"
  • 28/01/2019 - Giorgio Valle, Dipartimento di Biologia, Università di Padova - "Transcriptome analysis: from RNAseq to single cell RNA sequencing"
  • 22/01/2019 - Rubén Quintana Cabrera, Institute of Functional Biology and Genomics, University of Salamanca - "Extending the boundaries of mitochondrial dynamics"
  • 15/01/2019 - Giuseppe Astori, Unità Operativa Complessa di Ematologia - Azienda ULSS 8 Berica (Vicenza) - "La produzione dei medicinali per terapia cellulare avanzata : aspetti regolatori e sfide produttive in cell factory"